跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Sergivell Plain - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Sergivell Plain
Approved
STANDARD
Sergivell Plain
HBM Pharma S.R.O
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
70896d68f9a53c39
Company
HBM Pharma S.R.O
Type
Standard
Approval Details
Approval Id
70896d68f9a53c39
Drug Approval Philippines Name
Sergivell Plain
Product Name
Sergivell Plain
Registration Number
DRP-11591-01
Brand Name
Sergivell Plain
Generic Name
Bupivacaine Hydrochloride
Dosage Form
Solution for Intrathecal Injection
Dosage Strength
5 mg/ mL (0.5% w/v)
Manufacturer
HBM Pharma S.R.O
Importer
Ambica International Corporation
Distributor
Generics Pharmacal Phils., Inc
Issuance Date
28 September 2022
Expiry Date
01 April 2027
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
70896d68f9a53c39
Type
Standard
Back to Philippines FDA Approvals